Q: Could you please comment on the recent Q1 report for Vitalhub? Has your confidence in this company's future increased or diminished as a result? Thanks so much - your service to the DIY investing community is remarkable. You are my #1 go-to source for stock research.
5i Research Answer:
EPS of 4c beat estimates of 3.9c; revenue of $15.25M beat estimates of $14.28M. EBITDA of $4.04M beat estimates of $3.77M. Sales rose 21%. Recurring revenue also rose 21%. Gross margins were good at 81%. Cash was $33.3M, but more than $70M with the recent financing. Comments in the press release and the call were generally positive and it looks like VHI has a solid outlook. We would be a bit more positive today; we like the growth and positive momentum, with enthusiasm offset a little bit by valuation.